These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35021944)

  • 21. Interleukin-17 mRNA expression and serum levels in Behçet's disease.
    Jadideslam G; Kahroba H; Ansarin K; Sakhinia E; Abhar A; Alipour S; Farhadi J; Seydi Shirvani S; Nouri-Vaskeh M; Mousavi S; Khabbazi A
    Cytokine; 2020 Mar; 127():154994. PubMed ID: 31951967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imbalance of Th17 to Th1 cells in Behçet's disease.
    Kim J; Park JA; Lee EY; Lee YJ; Song YW; Lee EB
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S16-9. PubMed ID: 20868565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the liver X receptor inhibits Th17 and Th1 responses in Behcet's disease and Vogt-Koyanagi-Harada disease.
    Wu L; Wen H; Zhou Y; Yu H; Liu Y; Bai L; Kijlstra A; Yang P
    Curr Mol Med; 2014; 14(6):712-22. PubMed ID: 25056541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-155 regulates the Th17 immune response by targeting Ets-1 in Behçet's disease.
    Na SY; Park MJ; Park S; Lee ES
    Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S56-S63. PubMed ID: 27156371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-200a expression in CD4+ T cells correlates with the expression of Th17/Treg cells and relevant cytokines in psoriasis vulgaris: A case control study.
    Wang XY; Chen XY; Li J; Zhang HY; Liu J; Sun LD
    Biomed Pharmacother; 2017 Sep; 93():1158-1164. PubMed ID: 28738533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
    Na SY; Park MJ; Park S; Lee ES
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):32-40. PubMed ID: 24064012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease.
    Aktas Cetin E; Cosan F; Cefle A; Deniz G
    Mod Rheumatol; 2014 Sep; 24(5):802-7. PubMed ID: 24498963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Interferon alfa-2a Treatment on Adaptive and Innate Immune Systems in Patients With Behçet Disease Uveitis.
    Albayrak O; Oray M; Can F; Uludag Kirimli G; Gul A; Tugal-Tutkun I; Onal S
    Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):52-63. PubMed ID: 30601931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-26 is overexpressed in Behçet's disease and enhances Th17 related -cytokines.
    Kaabachi W; Bouali E; Berraïes A; Dhifallh IB; Hamdi B; Hamzaoui K; Hamzaoui A
    Immunol Lett; 2017 Oct; 190():177-184. PubMed ID: 28811236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2.
    Tahmasebi S; Saeed BQ; Temirgalieva E; Yumashev AV; El-Esawi MA; Navashenaq JG; Valizadeh H; Sadeghi A; Aslani S; Yousefi M; Jadidi-Niaragh F; Adigozalou J; Ahmadi M; Roshangar L
    Life Sci; 2021 Jul; 276():119437. PubMed ID: 33789145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial.
    Dolati S; Aghebati-Maleki L; Ahmadi M; Marofi F; Babaloo Z; Ayramloo H; Jafarisavari Z; Oskouei H; Afkham A; Younesi V; Nouri M; Yousefi M
    J Cell Physiol; 2018 Jul; 233(7):5222-5230. PubMed ID: 29194612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
    Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H
    Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease.
    Gelmez MY; Cinar S; Cetin EA; Ozcit-Gürel G; Babuna-Kobaner G; Erdugan M; Gul A; Akdag-Kose A; Deniz G
    Immunol Lett; 2021 Jul; 235():1-8. PubMed ID: 33901541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased interleukin 27 expression is associated with active uveitis in Behçet's disease.
    Wang C; Tian Y; Ye Z; Kijlstra A; Zhou Y; Yang P
    Arthritis Res Ther; 2014 May; 16(3):R117. PubMed ID: 24887071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators.
    Dolati S; Ahmadi M; Aghebti-Maleki L; Nikmaram A; Marofi F; Rikhtegar R; Ayromlou H; Yousefi M
    Pharmacol Rep; 2018 Dec; 70(6):1158-1167. PubMed ID: 30340096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of 1,25-dihydroxyvitamin D3 on Th17 and Th1 response in patients with Behçet's disease.
    Tian Y; Wang C; Ye Z; Xiao X; Kijlstra A; Yang P
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6434-41. PubMed ID: 22918640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A possible role for interleukin 37 in the pathogenesis of Behcet's disease.
    Ye Z; Wang C; Kijlstra A; Zhou X; Yang P
    Curr Mol Med; 2014 May; 14(4):535-42. PubMed ID: 24730521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-17A and IFN-γ are Up-regulated in CD4 and γδ T Cells in Active Behcet's Disease Patients.
    Abbasova V; Gül A; Saruhan-Direskeneli G
    Immunol Lett; 2022 Feb; 242():37-45. PubMed ID: 34838533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of IL-22- and TNF-α-producing Th22 cells in uveitis patients with Behcet's disease.
    Sugita S; Kawazoe Y; Imai A; Kawaguchi T; Horie S; Keino H; Takahashi M; Mochizuki M
    J Immunol; 2013 Jun; 190(11):5799-808. PubMed ID: 23630362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An elevated pro-inflammatory cytokines profile in Behcet's disease: A multiplex analysis.
    Gholijani N; Ataollahi MR; Samiei A; Aflaki E; Shenavandeh S; Kamali-Sarvestani E
    Immunol Lett; 2017 Jun; 186():46-51. PubMed ID: 27939191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.